JPMorgan Chase Financial Co. LLC has filed a pricing supplement for $1 million in auto callable contingent interest notes linked to the MerQube US Tech+ Vol Advantage Index. This filing, dated October 21, 2026, highlights the company's strategy to enhance its structured investment offerings.
The notes are designed for investors seeking contingent interest payments based on the performance of the underlying index. The filing indicates that the notes will be automatically called if the index's closing level meets certain thresholds, which could provide investors with attractive returns under specific market conditions.
Background
JPMorgan Chase Financial Co. LLC is a wholly owned finance subsidiary of JPMorgan Chase & Co., a leading player in the national commercial banking sector (SIC: 6021). The company is incorporated in Delaware and has its business address at 383 Madison Avenue, New York, NY. Recent filings include several pricing supplements, indicating active engagement in structured finance.
What the Filing Says
The filing details the terms of the notes, stating, "The notes are designed for investors who seek a Contingent Interest Payment with respect to each monthly Interest Review Date for which the closing level of the MerQube US Tech+ Vol Advantage Index... is greater than or equal to 85.00% of the Initial Value." The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co., emphasizing their backing by a major financial institution.
Impact
This offering may impact investors looking for structured products with contingent interest features. It also highlights JPMorgan's competitive positioning in the structured investment market, which could influence other financial institutions in the national commercial banking sector. Investors will need to consider the associated risks, including the potential for losing a significant portion of their principal.
What's Next
The notes are expected to settle on or about October 22, 2026. Further details regarding the performance of the notes and investor interest will likely emerge in subsequent filings.
Read Next
Sunrun Inc. Amends Bylaws to Enhance Governance Practices
Bioxytran launches first two nutraceutical products
Ericsson announces share buyback program for November 2026
Ferrari announces share buyback as part of €3.5 billion program
American Express Reports Delinquency and Write-off Statistics
Novo Nordisk announces DKK 15 billion share repurchase plan










